New Owner
Bristol-Myers Squibb - Flexus Biosciences
Bristol-Myers Squibb acquires Flexus Biosciences
Announced: February 23, 2015
Type: Acquisition
Disposition: Combined
Status: Complete
Amount: $ 1,250,000,000